Nonoperating Income (Expense) in USD of Kiromic Biopharma, Inc. from Q2 2023 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Kiromic Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2023 to 2024.
  • Kiromic Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$832K, a 161% decline year-over-year.
  • Kiromic Biopharma, Inc. annual Nonoperating Income (Expense) for 2024 was -$3.12M, a 209% decline from 2023.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

Kiromic Biopharma, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$832K -$2.19M -161% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$472K +$2M +80.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q3 2023 $1.36M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$2.47M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09

Kiromic Biopharma, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3.12M -$2.11M -209% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 -$1.01M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.